Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents

急性 COVID-19 患者和 COVID-19 康复患者 B 细胞和滤泡辅助性 T 细胞亚群的改变

阅读:1
作者:Igor V Kudryavtsev ,Natalia A Arsentieva ,Oleg K Batsunov ,Zoia R Korobova ,Irina V Khamitova ,Dmitrii V Isakov ,Raisa N Kuznetsova ,Artem A Rubinstein ,Oksana V Stanevich ,Aleksandra A Lebedeva ,Evgeny A Vorobyov ,Snejana V Vorobyova ,Alexander N Kulikov ,Maria A Sharapova ,Dmitrii E Pevtcov ,Areg A Totolian

Abstract

Background: Humoral immunity requires interaction between B cell and T follicular helper cells (Tfh) to produce effective immune response, but the data regarding a role of B cells and Tfh in SARS-CoV-2 defense are still sparse. Methods: Blood samples from patients with acute COVID-19 (n = 64), convalescents patients who had specific IgG to SARS-CoV-2 N-protein (n = 55), and healthy donors with no detectable antibodies to any SARS-CoV-2 proteins (HC, n = 44) were analyses by multicolor flow cytometry. Results: Patients with acute COVID-19 showed decreased levels of memory B cells subsets and increased proportion plasma cell precursors compared to HC and COVID-19 convalescent patients, whereas for the latter the elevated numbers of virgin naïve, Bm2' and "Bm3+Bm4" was found if compared with HC. During acute COVID-19 CXCR3+CCR6- Tfh1-like cells were decreased and the levels of CXCR3-CCR6+ Tfh17-like were increased then in HC and convalescent patients. Finally, COVID-19 convalescent patients had increased levels of Tfh2-, Tfh17- and DP Tfh-like cells while comparing their amount with HC. Conclusions: Our data indicate that COVID-19 can impact the humoral immunity in the long-term.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。